Found: 27
Select item for more details and to access through your institution.
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 16, p. 14761, doi. 10.1007/s00432-023-05243-7
- By:
- Publication type:
- Article
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2491, doi. 10.1007/s00432-022-04082-2
- By:
- Publication type:
- Article
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2041, doi. 10.3390/jpm12122041
- By:
- Publication type:
- Article
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.819985
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4835653
- By:
- Publication type:
- Article
ASO Author Reflections: Neoadjuvant Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin Is an Incredible Helper in Curing Patients with Intermediate-Advanced-Stage and Technically Resectable Hepatocellular Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 3, p. 2030, doi. 10.1245/s10434-021-11028-4
- By:
- Publication type:
- Article
ASO Visual Abstract: Comparison between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate/Advanced-Stage Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 3, p. 2016, doi. 10.1245/s10434-021-10903-4
- By:
- Publication type:
- Article
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.819985
- By:
- Publication type:
- Article
A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 6869, doi. 10.2147/JIR.S397375
- By:
- Publication type:
- Article
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12940-0
- By:
- Publication type:
- Article
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.
- Published in:
- Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 463, doi. 10.2147/JHC.S447387
- By:
- Publication type:
- Article
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 324, doi. 10.3390/jcm12010324
- By:
- Publication type:
- Article
Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 378, doi. 10.3390/cancers10100378
- By:
- Publication type:
- Article
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 5721, doi. 10.2147/JIR.S385921
- By:
- Publication type:
- Article
A novel inflammation‐based nomogram system to predict survival of patients with hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 10, p. 5027, doi. 10.1002/cam4.1787
- By:
- Publication type:
- Article
Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1138355
- By:
- Publication type:
- Article
Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 7, p. 1006, doi. 10.1111/jcmm.17718
- By:
- Publication type:
- Article
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8<sup>+</sup> T cell recruitment.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02097-6
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1234342
- By:
- Publication type:
- Article
Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1210835
- By:
- Publication type:
- Article
The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241237631
- By:
- Publication type:
- Article
Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e487, doi. 10.1093/oncolo/oyad277
- By:
- Publication type:
- Article
The apolipoprotein B and apolipoprotein A-I Ratio serves as a strong prognostic factor for the overall survival of patients with colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1089688
- By:
- Publication type:
- Article
A risk‐based postresection follow‐up strategy for hepatocellular carcinoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 569, doi. 10.1002/cncr.34601
- By:
- Publication type:
- Article
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60379-x
- By:
- Publication type:
- Article
PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.568015
- By:
- Publication type:
- Article